<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD002284-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD002284-sec-0008"></div> <div class="table" id="CD002284-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings ‐ fluoride mouthrinse compared with placebo or no treatment for preventing caries in children and adolescents</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Fluoride mouthrinse compared with placebo or no treatment for preventing caries in children and adolescents</b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> children and adolescents<br><b>Setting:</b> community (schools)<br><b>Intervention:</b> fluoride mouthrinse (primarily supervised use in school setting)<br><b>Comparison:</b> placebo or no treatment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Outcomes</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell table-tint"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Relative effect<br>(95% CI)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Number of participants<br>(studies)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Quality of the evidence<br>(GRADE)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="2" class="headercell"> <p><b>Comments</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk with placebo or no treatment (assumed risk)</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell table-tint"> <p><b>Risk with fluoride mouthrinse (corresponding risk)</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Changes in caries on the surfaces of permanent teeth</b> measured by </p> <p>D(M)FS increment ‐ nearest to 3 years</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean increment ranged across control groups from 0.74 to 21.05, median 5.6</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The corresponding mean increment in the intervention group is 3.80 (95% CI 3.64 to 4.00) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>PF</b><sup>a</sup> 0.27<br>(0.23 to 0.30) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15305<br>(35 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>moderate</b><sup>b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Large effect:</p> <p>D(M)FS PF 27% (23% to 30%)</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Changes in caries on the permanent teeth</b> measured by </p> <p>D(M)FT increment ‐ nearest to 3 years</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Mean increment ranged across control groups from 0.72 to 8.41, median 3.2</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The corresponding mean increment in the intervention group is 2.46 (95% CI 2.27 to 2.62) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>PF</b><sup>a</sup> 0.23<br>(0.18 to 0.29) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5105<br>(13 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br><b>moderate</b><sup>b</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Moderate to large effect:</p> <p>D(M)FT PF 23% (18% to 29%)</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unacceptability of treatment as measured by leaving study early</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>149 per 1000</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>198 per 1000<br>(92 to 422) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR</b> 1.33<br>(0.62 to 2.83) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1700<br>(4 RCTs) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br><b>very low</b><sup>b,c,d</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tooth staining</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>Study 1: "significant difference" in stain score (from the control) in the group using an amine fluoride mouthrinse: </p> <p>"non‐significant difference" (from the control) in the group using sodium fluoride</p> <p>In 2 trials where stannous fluoride mouthrinsing was tested against placebo rinsing:</p> <p>Study 2: "approximately six children had tenacious staining that required a rubber cup prophylaxis carried out" ‐ no indication as to which groups these children belonged </p> <p>Study 3: "some amount of yellow pigmentation, somewhat more noticeable in the children in the test group" </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study 1: 525</p> <p>Study 2: 743</p> <p>Study 3: 726</p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>very low</b><sup>e</sup></p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We know little about the risk of tooth staining owing to incomplete reporting</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Signs of acute toxicity during application of treatment (such as nausea/gagging/vomiting)</p> </td> <td align="" valign="" colspan="5" rowspan="1" class="table-tint table-highlight"> <p>Not reported in any studies</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No data on signs of acute toxicity</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mucosal irritation/oral soft tissue allergic reaction</p> </td> <td align="" valign="" colspan="3" rowspan="1" class="table-tint table-highlight"> <p>"no cases of mucosal hypersensitivity after periodical examinations of every subject" ‐ reported in 1 study </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>434</p> <p>(1 RCT)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝</p> <p><b>very low</b><sup>e</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We know very little about the risk of mucosal irritation/allergic reaction owing to lack of reporting </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk, the risk in the placebo or no treatment group,</b> was the range and median in the control groups of the studies included in the review. The<b>corresponding risk, the risk in the intervention group</b><b>(and its 95% confidence interval),</b> is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br>CI = confidence interval; D(M)FS = decayed (missing) and filled permanent surfaces; D(M)FT = decayed (missing) and filled permanent teeth; PF = prevented fraction; RR = risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is different.<br><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>PF = 1 ‐ (mean increment in control group/mean increment in treatment group) (expressed as percentages). PF values between 1% and 10% are considered to be a small effect; between 10% and 20%, a moderate effect; above 20% a large or substantial effect.<br><sup>b</sup>All studies were at unclear or high risk of bias. Trials had unclear or high risk of bias in sequence generation and allocation concealment. Most studies had supervised mouthrinsing conducted in the school setting ‐ this was considered for indirectness but downgrading considered unnecessary. </p> <p><sup>c</sup>Wide confidence interval ‐ small number of participants analysed. </p> <p><sup>d</sup>High unexplained heterogeneity observed. </p> <p><sup>e</sup>Incomplete information from one to three trials with unclear or high risk of bias. Outcome downgraded for concerns of risk of bias and serious imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
